At USP Biologics our primary objective is to keep you at the vanguard of standards that promote the quality of biological medicines. We do this through our rigorous and proven scientific process. And we place the outcome of our process – the physical standard as well as the method or supporting information– into your hands.

We provide a trusted, independent, single source of reliable standards that are available and used globally. Building upon our successes with more traditional biologics including Insulin and Heparin, we engage with thousands of experts, professionals, associations, regulatory agencies, and companies to pave the way for higher standards for the new wave of biologics and biosimilar drugs. It’s logical really: by actively working with the scientific community and making our rigorously researched standards available to the world, we enable you to provide access to quality medicines for all. Through a collaborative process and commitment to quality, our USP’s biologic standards help by delivering key tools and resources to help make critical medicines, such as the insulin family of products, more accessible to the global population.

To assist you in achieving high standards in drug validation and regulatory compliance as well as avoiding potentially costly mistakes, choose our globally renowned scientific approach that has provided trustworthy standards for decades. Logical really.

Our process is as robust as the results you will achieve. So why not talk with us and find out how we can help advance your biologics and biosimilars project with reliable standards?